Anti-Human CD221 Recombinant Antibody(Robatumumab)

Product Information

Catalog Number	YR1196
Product Name	Anti-Human CD221 Recombinant Antibody(Robatumumab)
Molecular Name	Robatumumab
Alias	Anti-CD221 Recombinant Antibody, Research Grade Robatumumab
CAS Number	934235-44-6
Target	CD221[Homo sapiens]
Isotype	IgG1 Kappa
Clonity	Monoclonal
Source	CHO Cells
Size	1mg, 5mg
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Applications	FuncS, IF, Neut, ELISA, FCM, IP
Buffer	PBS, pH7.5
Background	Robatumumab (proposed INN, also known as SCH 717454 and MK-7454) is a monoclonal antibody and an antineoplastic by Merck and Schering-Plough. It binds to CD221, the insulin-like growth factor 1 receptor. Phase 2 clinical trials in patients with colorectal cancer, osteosarcoma and Ewing's sarcoma are complete. Merck has since discontinued development.
Storage	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Note	This product is for research use only.

Cat#	Product Name	Species	Host	Applications	Size	Price